Cancer patients and COVID-19 vaccination, from safety to protocol adherence: A real-life setting report

ABSTRACT:

Background

The SARS-CoV-2 pandemic has slowed down cancer prevention and treatment strategies; consequently, cancer patients are prioritized to get the COVID-19 vaccines. Being constantly threatened by a new outbreak, the dive within the immunogenicity response is of great value; nonetheless, evaluating the side effects of these vaccines on fragile patients will assure their adherence to the vaccination protocol.

Objectives

This study sets out to investigate the adverse events reported about the vaccine according to its doses and types, and to compare the prevalence and severity of toxicities across two subgroups of cancer patients, those who received the injection during active therapy cycles, and those who have not started the therapy yet at vaccination time, moreover,

SUBMITTER:  

PROVIDER: S-EPMC9573984 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature